JP2012229264A5 - - Google Patents

Download PDF

Info

Publication number
JP2012229264A5
JP2012229264A5 JP2012167155A JP2012167155A JP2012229264A5 JP 2012229264 A5 JP2012229264 A5 JP 2012229264A5 JP 2012167155 A JP2012167155 A JP 2012167155A JP 2012167155 A JP2012167155 A JP 2012167155A JP 2012229264 A5 JP2012229264 A5 JP 2012229264A5
Authority
JP
Japan
Prior art keywords
compound
composition
diarrhea
formula
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012167155A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012229264A (ja
JP5825217B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012167155A priority Critical patent/JP5825217B2/ja
Priority claimed from JP2012167155A external-priority patent/JP5825217B2/ja
Publication of JP2012229264A publication Critical patent/JP2012229264A/ja
Publication of JP2012229264A5 publication Critical patent/JP2012229264A5/ja
Application granted granted Critical
Publication of JP5825217B2 publication Critical patent/JP5825217B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2012167155A 2012-07-27 2012-07-27 １８員大環状化合物及びその類似化合物 Expired - Lifetime JP5825217B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012167155A JP5825217B2 (ja) 2012-07-27 2012-07-27 １８員大環状化合物及びその類似化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012167155A JP5825217B2 (ja) 2012-07-27 2012-07-27 １８員大環状化合物及びその類似化合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007553073A Division JP5166040B2 (ja) 2005-01-31 2005-01-31 １８員大環状化合物及びその類似化合物

Publications (3)

Publication Number Publication Date
JP2012229264A JP2012229264A (ja) 2012-11-22
JP2012229264A5 true JP2012229264A5 (cg-RX-API-DMAC10.html) 2013-05-09
JP5825217B2 JP5825217B2 (ja) 2015-12-02

Family

ID=47431109

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012167155A Expired - Lifetime JP5825217B2 (ja) 2012-07-27 2012-07-27 １８員大環状化合物及びその類似化合物

Country Status (1)

Country Link
JP (1) JP5825217B2 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH065185B2 (ja) 1985-10-30 1994-01-19 鎮▲かく▼ 東島 分力計測方法および装置
JP5935853B2 (ja) * 2014-09-30 2016-06-15 株式会社明電舎 ダイナモメータシステムの制御装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4918174A (en) * 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
US5583115A (en) * 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds

Similar Documents

Publication Publication Date Title
JP2015078230A5 (cg-RX-API-DMAC10.html)
JP2012255026A5 (cg-RX-API-DMAC10.html)
HRP20171961T1 (hr) Kemijski spojevi
JP2013032389A5 (cg-RX-API-DMAC10.html)
JP2014507482A5 (cg-RX-API-DMAC10.html)
JP2013014622A5 (cg-RX-API-DMAC10.html)
CA2894891A1 (en) Boronic acid derivatives and therapeutic uses thereof
IL218598A (en) Oral solid dosage form containing nanoparticles and process for preparation using gelatin from fish
HRP20180237T4 (hr) Metode za liječenje hcv-a
JP2011105738A5 (cg-RX-API-DMAC10.html)
CL2013000677A1 (es) Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn.
JP2011518833A5 (cg-RX-API-DMAC10.html)
MD20140073A2 (en) New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
UA111972C2 (uk) Вагінальна таблетка, яка містить рифаксимін, спосіб її виготовлення та застосування для лікування вагінальних інфекцій
JP2014205701A5 (cg-RX-API-DMAC10.html)
MX2014011787A (es) Formulaciones farmaceuticas que comprenden antagonistas de ccr3.
MX383411B (es) Limpiador de horno de dosis unitaria de tableta sólida.
PT2389070E (pt) Formulações desintegráveis de carbonato de lantânio
IN2013MU02911A (cg-RX-API-DMAC10.html)
FI3509595T3 (fi) Hydroksipyridonaattiaktinidi-/lantanididekorporaatioaineiden formulaatioita
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
JP2014062109A5 (cg-RX-API-DMAC10.html)
MX2013012773A (es) Sustancias farmacologicas, composiciones farmaceuticas y metodos para la preparacion de las mismas.
JP2015500340A5 (cg-RX-API-DMAC10.html)
WO2014006635A3 (en) Solid oral compositions of silodosin